Alternatively, when systolic blood pressure, total cholesterol, and use of ACEi/ARB, statin and sodium-glucose cotransporter 2 inhibitors were included as independent variables in the models and hypertension, hyperlipidemia, and use of OHAs were excluded, plasma galectin-3 concentrations were still associated with eGFR (Supplementary Table 1). This evidence concerns the gene SLC5A2 and hyperlipidemia.